SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-047434
Filing Date
2022-08-12
Accepted
2022-08-12 16:31:27
Documents
52
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_orionbiotech.htm   iXBRL 10-Q 532234
2 CERTIFICATION f10q0622ex31-1_orionbio.htm EX-31.1 12270
3 CERTIFICATION f10q0622ex31-2_orionbio.htm EX-31.2 12323
4 CERTIFICATION f10q0622ex32-1_orionbio.htm EX-32.1 4550
5 CERTIFICATION f10q0622ex32-2_orionbio.htm EX-32.2 4323
  Complete submission text file 0001213900-22-047434.txt   3406344

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE oria-20220630.xsd EX-101.SCH 48366
7 XBRL CALCULATION FILE oria-20220630_cal.xml EX-101.CAL 21208
8 XBRL DEFINITION FILE oria-20220630_def.xml EX-101.DEF 194360
9 XBRL LABEL FILE oria-20220630_lab.xml EX-101.LAB 351247
10 XBRL PRESENTATION FILE oria-20220630_pre.xml EX-101.PRE 200190
46 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_orionbiotech_htm.xml XML 356104
Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40410 | Film No.: 221160626
SIC: 6770 Blank Checks
Office of Real Estate & Construction